SCHEMBL29611983

SCHEMBL29611983

C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 10/20 0.54
▸ NPY1R P25929 7/20 0.54
▸ NPY2R P49146 5/20 0.54
▸ NPY5R Q15761 4/20 0.54
▸ LNPEP Q9UIQ6 2/20 0.51
▸ ERAP2 Q6P179 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8908390 0.91 LNPEP (0.55) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL29531489 0.91 LNPEP (0.55) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL29868753 0.88 LNPEP (0.55) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL30266816 0.87 LNPEP (0.60) NPY4RNPY1RNPY2RLNPEPERAP2
SCHEMBL30090915 0.86 LNPEP (0.64) NPY4RNPY1RNPY2RLNPEPERAP2
SCHEMBL23510635 0.85 LNPEP (0.60) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL23510636 0.85 LNPEP (0.60) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL29619337 0.85 LNPEP (0.53) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL30178189 0.85 LNPEP (0.51) NPY4RNPY1RNPY2RNPY5RLNPEP
SCHEMBL30931517 0.84 LNPEP (0.62) NPY4RNPY1RNPY2RNPY5RLNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12419824-B2 Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes LUBRIZOL ADVANCED MATERIALS, INC. (US) 2025-09-23 — — US disclosed
US-20220183950-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES LUBRIZOL ADVANCED MATERIALS, INC. (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220183950-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES TYR, TELO2, MTX2 NPY4R 124/4885NPY1R 65/4885NPY2R 52/4885
US-12419824-B2 Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes TYR, TELO2, MTX2 NPY4R 124/4885NPY1R 65/4885NPY2R 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback